Tissue Bank Services Market

The global market value of the tissue bank services market was valued at USD 2.5 billion in 2024 and is projected to grow at a CAGR of 9.8% during the forecast period. An increasing number of patients suffering from chronic diseases and a rising number of transplantations, including cornea and heart valves, are driving growth in the market. Increasing demand for tissues in organ transplantation and improvements in cryopreservation and other preservation techniques are driving growth in the market. The partnership between tissue banks, research institutions, and pharmaceutical companies is the key factor behind the growth in the market.

Growth Drivers

A rising aging population and a rise in chronic diseases are the key factors behind the market growth.

Significant growth in the preservation of tissues owing to tremendous advancement in medical research, clinical trials, and biopharmaceutical industries has boosted the market for tissue banking products and services. In addition, advances in regenerative medicine, biobanking, and drug discovery; increased investments by governments and non-governmental and corporate organizations; and advances in the treatment of cell and tissue disorders are factors expected to boost the growth and development of the tissue banking market.

Rising healthcare expenditure all over the world is the key factor behind the market growth. Increasing cases of organ and tissue failure due to trauma, chronic diseases, and the aging population are driving growth in the market. Growth in bone grafts, skin grafts, and heart valves is fueling demand in the market. Improved methods for storing tissues for longer periods without degradation are the key factors behind the growth in the market. An increasing number of patients with diabetes, cardiovascular diseases, and osteoporosis often require tissue grafting and replacement. Orthopedic and dental surgeries require tissue implants. Funding for public tissue banks and research institutions has increased.

Segmentation

Product

·         Equipment

·         Cryopreservation Equipment

·         Thawing Equipment

·         Quality Control Equipment

·         Others

·         Media and Consumables

Tissue Type

·         Heart Valves

·         Cornea

·         Brain and Spinal Cord

·         Bone and Skin

Application

·         Therapeutic

·         Cosmetic

·         Research and Development

·         Drug Discovery

End-User

·         Biobanks

·         Hospitals and Clinics

By Region

·         Asia Pacific

·         North America

·         Latin America

·         Middle East and Africa

The Tissue Banking Market by Tissue Type Segmentation

Based on the tissue type, the tissue banking market is segmented into heart valves, corneas, brains and spinal cords, and bones and skin. Bone and Skin is the leading segment because of the high success rate of bone grafting procedures. Increasing growth in 3D printing and allograft processing technologies has driven the market towards growth.

Increasing demand for skin grafts in burn wounds and plastic and reconstructive surgeries is fueling the market growth. Despite the increasing number of cardiovascular cases, the growth in heart valve tissue market share is less in comparison to bone and skin tissues. Cornea transplants are also witnessing moderate growth. Brain and spinal cord tissues are used in research and development activities but are not useful in transplantation. An increasing need for transplantable tissues is anticipated to propel a notable rise in both supply and research efforts, thereby greatly affecting the development dynamics of the global tissue banking market industry.

Regional Outlook

Based on the regions, the tissue banking market is analyzed into 5 regions: Asia-Pacific, North America, Latin America, Middle East and Africa, and Europe. North America is the leading region in the market and is expected to dominate the market during the forecast period. The region boasts a well-established healthcare system with cutting-edge technologies and facilities. Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to the rising health awareness among the people and the growing demand for advanced medical technology.

The rapidly growing population in the countries like China, and India is the key factor behind the significant growth in the tissue banking market. Rising healthcare expenditures and growing awareness of regenerative medicines is fueling the market growth significantly. Educational initiatives are increasing public understanding of the benefits of tissue donation, and storage. Programs aimed at promoting tissue donation, and storage are contributing to market expansion.

North America holds the largest share of the global tissue banking market due to the high prevalence of chronic diseases, such as heart diseases, and diabetes. The presence of leading biopharmaceutical companies and substantial investment in healthcare research bolster the demand for high-quality tissue samples. Innovations in cryopreservation, and tissue storage technologies enhance the efficiency and safety of tissue banking processes. Stringent standards and guidelines ensure the quality and safety of tissue banking practices fostering trust and reliability of tissue banks.

The presence of major key players in the region like Thermofisher Scientific, BioLife Solutions, and Brooks Automation among others. Due to the advancement in healthcare infrastructure, the tissue banking services market in Europe, the Middle East and Africa, and Latin America is experiencing significant growth, driven by advancements in healthcare infrastructure, increasing awareness about tissue donation, and increasing research and development activities are the key factors behind the market growth.

A rising prevalence of life-threatening diseases such as heart disease, and cancer is the key reason behind the market growth. The EU Tissue Directive establishes stringent standards for the donation, procurement, processing, testing, and distribution of human tissues and cells intended for human application, ensuring quality and safety. Rising awareness of tissue donation, and improving healthcare infrastructure is the reasons behind the growth in the Middle East and African market growth. Orthopedics, Musculoskeletal, and spine applications dominate the markets, with cardiac and vascular segments showing rapid growth.

The Latin American Market is witnessing steady growth due to the increasing number of chronic disease patients, and increasing demand for tissue donation in the region. Immunohistochemistry is the largest segment contributing in the market’s growth.

Key Players

·         Thermo Fisher Scientific, Inc.

·         Sigma-Aldrich Corporation

·         Panasonic Biomedical Sales Europe B.V.,

·         Custom BioGenic Systems

·         Taylor-Wharton International LLC

·         AbD Serotec (a Bio-Rad company)

·         EMD Millipore Corporation

·         Organ Recovery Systems, Inc.

·         BioCision LLC

·         Teva Pharmaceutical Industries and Ltd.

·         Genzyme Corporation

·         Fisher BioServices, Inc.

·         EPL Archives, Inc.

·         BioStorage Technologies, Inc.

·         AMS Biotechnology Limited

·         Eppendorf AG

·         Beckman Coulter, Inc.

·         Other Players